NCT06204081

Brief Summary

The Ceriter Stride One (CSO) is a "smart sole" with pressure sensors. The sole allows data on the displacement of the body's centre of gravity (COG), as well as spatiotemporal parameters, to be obtained via pressure recordings. Logarithms, released on the data captured by the sole, make it possible to recognise propulsion (forward movement of the CG), accompanied by a reduction in step length (festination) or feet remaining standing (freezing of gait). When the system registers incipient propulsion, an audio signal ("stop") is generated via an audio device and app on the mobile phone. The CSO aims to make the pwP stop before balance disturbance can occur, preventing further propulsion and falls. The aim of the study is to explore the short-term effects of the CSO in terms of reducing (preventing) freezing of gait and fall risk in a pilot group of pwP whose functionality is limited (Hoehn and Yahr 4). Short-term impact on gait (episodes of freezing of gait, mean step length, mean gait speed) will be evaluated and user satisfaction surveyed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

December 5, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 12, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 14, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 14, 2024

Completed
Last Updated

June 5, 2024

Status Verified

June 1, 2024

Enrollment Period

5 months

First QC Date

December 1, 2023

Last Update Submit

June 4, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • The number of captured episodes with freezing of gait (FOG)

    n (number of captured FOG-episodes : the less, the better)

    2 times 3 minutes

  • The number of captured steps

    n (number - more steps relate to a better mobility)

    2 times 3 minutes

  • The difference between the pressure of steps with left versus right foot; as a measure of gait asymmetry.

    mean presure data of left foot versus mean pressure data of right foot

    2 times 3 minutes

  • mean step length

    mean step length (cm)

    2 times 3 minutes

Secondary Outcomes (1)

  • users satisfaction

    after testing (5 min)

Study Arms (1)

persons with Parkinson's Disease, Hoehn & Yahr stage 4, FOG

EXPERIMENTAL

This group tests first without the use of cues (CSO evaluates gait pattern, but does not adjust), and then with cues.

Device: CSO_without cueingDevice: CSO_cueing

Interventions

The sole is worn without using the cueing application

persons with Parkinson's Disease, Hoehn & Yahr stage 4, FOG

The sole is worn with using the cueing application

persons with Parkinson's Disease, Hoehn & Yahr stage 4, FOG

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Parkinson's disease (or other Parkinsonism)
  • gait impairment with freezing of gait (FOG)
  • years old
  • I.C. (informed consent)
  • Montreal Cognitive Assessment (MoCA) \>25

You may not qualify if:

  • unable to walk 4m without assistance
  • MoCA \< 25
  • no FOG

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghent University

Ghent, Oost-Vlaanderen, 9000, Belgium

Location

Related Publications (1)

  • Zoetewei D, Herman T, Brozgol M, Ginis P, Thumm PC, Ceulemans E, Decaluwe E, Palmerini L, Ferrari A, Nieuwboer A, Hausdorff JM. Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's disease. Contemp Clin Trials Commun. 2021 Jun 29;24:100817. doi: 10.1016/j.conctc.2021.100817. eCollection 2021 Dec.

Related Links

MeSH Terms

Conditions

Gait Disorders, NeurologicParkinson Disease

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsParkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Dirk Cambier, PhD

    UGent, FGE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Model Details: One experimental group of pwP (H\&Y stage 4, FOG) wear the sole a. 3 min. without using cues when FOG appears and b. 3 min. with using auditive cues when FOG appears. By randomisation of the conditions, the effect of cues on gait is studied.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2023

First Posted

January 12, 2024

Study Start

December 5, 2023

Primary Completion

May 14, 2024

Study Completion

May 14, 2024

Last Updated

June 5, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations